April 19, 2023
The University of Cincinnati is one of 50 nationwide trial sites for a new clinical trial testing a new treatment for status epilepticus, the most severe and deadly form of epilepsy.
April 24, 2023
The University of Cincinnati’s Paolo Palmisciano, MD, was part of an award-winning research team that examined how well a minimally invasive approach worked to limit vision and hearing loss in patients following brain tumor surgery and will present the research at the American Association of Neurological Surgeons annual scientific meeting.
April 21, 2023
The University of Cincinnati's Alberto Espay will present Parkinson's disease research at the American Academy of Neurology's annual meeting April 22-27 in Boston.
May 15, 2023
University of Cincinnati’s Melanie Thomas-Castillo, PsyD, and Stephen Rush, MD, recently published commentary on how psychiatrists can work to create a supportive environment for transgender and gender diverse patients in the journal Current Psychiatry.
May 18, 2023
The University of Cincinnati's Achala Vagal, MD, was featured in a Neurology Today article discussing the present and future of artificial intelligence in detecting strokes and predicting patient outcomes.
May 19, 2023
The University of Cincinnati Cancer Center's Syed Ahmad, MD, is the national principal investigator for a phase 2 trial testing the effectiveness of chemotherapy treatment following surgery for a subset of pancreatic cancer patients.
May 23, 2023
The University of Cincinnati's Steven Kniffley Jr., PsyD, was featured in an Associated Press article discussing how racism affects the mental health of Black children.
May 26, 2023
University of Cincinnati Cancer Center researchers will present abstracts at the American Society of Clinical Oncology (ASCO) annual meeting 2023, held in Chicago June 2-6.
December 12, 2022
Healio highlighted research led by the University of Cincinnati and Cincinnati Children's Hospital Medical Center's Jeffery Epstein that found a software program reduced the frequency of long glances away from the roadway among adolescent drivers with ADHD.
December 6, 2022
Forbes highlighted research from the University of Cincinnati's Jeffrey Mills and Jeffrey Strawn examining factors behind the decision to begin or decline medication treatment for childhood anxiety disorders after cognitive behavioral therapy did not lead to improvement.